haemalogix.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.haemalogix.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Immuno-Oncology and Immune
Description News & HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other
Keywords N/A
Server Information
WebSite haemalogix faviconhaemalogix.com
Host IP 185.230.63.107
Location -
Related Websites
Site Rank
More to Explore
haemalogix.com Valuation
US$1,365
Last updated: 2023-05-10 17:24:07

haemalogix.com has Semrush global rank of 0. haemalogix.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. haemalogix.com receives approximately 157 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, haemalogix.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,365
Daily Ads Revenue US$1
Monthly Ads Revenue US$37
Yearly Ads Revenue US$453
Daily Unique Visitors 10
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
haemalogix.com. A 3600 IP: 185.230.63.107
haemalogix.com. A 3600 IP: 185.230.63.171
haemalogix.com. A 3600 IP: 185.230.63.186
haemalogix.com. NS 86400 NS Record: ns3.wixdns.net.
haemalogix.com. NS 86400 NS Record: ns2.wixdns.net.
haemalogix.com. MX 3600 MX Record: 0 haemalogix-com.mail.protection.outlook.com.
HtmlToTextCheckTime:2023-05-10 17:24:07
top of page Home About us Management Team Scientific Advisory Board Board of Directors Pipeline Technology Monoclonal Antibodies CAR T Cell Therapies Bispecific Antibodies Publications Published Manuscripts Poster Presentations News News Releases Videos Newsletters Pioneering the development of novel immunotherapies for patients with blood cancers and B-cell disorders. News & Events Watch: Meet our team: Dr Geoffrey Nichol 9 May 2023 Read more Watch: For investors, interview series with Dr Geoffrey Nichol 2 May 2023 Read more HaemaLogiX announces issuance of Japanese patent for KMA.CAR T 3 April 2023 Read more Our Team The HaemaLogiX management team has deep expertise in immunotherapy development and the unique antigens that our treatments target. Our Scientific Advisory Board comprises internationally recognised experts in monoclonal antibodies and haematology. Team Our Pipeline We’re developing a suite of diverse immunotherapies including monoclonal antibodies, CAR-T cells and
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 03 Nov 2021 03:56:42 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.haemalogix.com/
strict-transport-security: max-age=120
Age: 72641
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVisPSpdvxhEEQZ13gnr6W/r,m0j2EEknGIVUW/liY8BLLk4c1TjfDNjZRW4gaj81MvVkavE0ZtMXws1mfakihq4B,2d58ifebGbosy5xc+FRalkY6s7ect7C5FX/+AbnFi2bo0awLgasNRb+y72fsvo1jSeW5YVrGfbWqg+RhZcSY8g==,2UNV7KOq4oGjA5+PKsX47I0wE1DRJbm7iPmGxzeugUZYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635911802.6391045473343187555
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 03 Nov 2021 03:56:42 GMT
content-type: text/html; charset=UTF-8
content-length: 793165
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"afccf491082b644a51255fe90050e1da"
content-language: en
strict-transport-security: max-age=120
age: 157065
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Mon, 01 Nov 2021 08:19:16 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YTTNfQwROSdUHmsxQxhbaDc=,jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6cMbwluI1yUDJty9McxOlfY,2d58ifebGbosy5xc+FRaliiq6SyvXdTrZOVcTvgwdpLKNx3lqWI6Ngt9u1xQT/LBWcTC7sDAv2XN8L0ee6v9Rg==,2UNV7KOq4oGjA5+PKsX47Br+ilU2OUaGN9cE2DqPolkfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635911802.79910466383293019347
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131b5205cddde182a6ed79147b2cefdb399d25911aa6aed01bace62c52606cbc07d84203c65f2510caef91a07e4be730878; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10
haemalogix.com Whois Information
Domain Name: HAEMALOGIX.COM
Registry Domain ID: 1888788139_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-12-05T16:50:28Z
Creation Date: 2014-12-05T03:59:52Z
Registry Expiry Date: 2021-12-05T03:59:52Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-29T09:05:55Z <<<